VJZ-18210-95992 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-23
Dose 1 — Pfizer-BioNTech
2021-05-14
Registered in v-safe
2021-05-14
Dose 2 — Pfizer-BioNTech
2021-11-12
Survey response — 6 months, dose 2
MedDRA: Ageusia, Anosmia, COVID-19, Nasal congestion, Rhinorrhoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Covid, runny nose stuffy, loss of taste and smell

MedDRA releases: 2024-11 · check-in free text available
2021-11-12
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · 1 call case(s)
2021-11-16
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-23	Pfizer-BioNTech
2	2021-05-14	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-11-12	Unsuccessful

Free text

Release 10 — 6 months, dose 2

2021-11-12

Symptoms: Covid, runny nose stuffy, loss of taste and smell

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Ageusia	·	·	✓
SD	Anosmia	·	·	✓
SD	COVID-19	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release